Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision label was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a small frontend update to the study details page. This change does not modify study content or data.
    Difference
    0.0%
    Check dated 2026-07-23T08:37:38.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page shows a new revision tag: v3.6.3, replacing the previous v3.6.1. This indicates a newer version of the page content.
    Difference
    0.0%
    Check dated 2026-07-02T03:20:33.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.6.1 is now displayed, replacing the previous v3.6.0. This reflects a frontend version update and does not modify study details or content on the page.
    Difference
    0.0%
    Check dated 2026-06-25T00:15:39.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The study page now shows 'No longer looking for participants', signaling that recruitment is closed for this study. Additional navigational or labeling updates were applied, including new sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and a minor heading formatting change from 'Intervention / Treatment' to 'Intervention/Treatment'.
    Difference
    0.2%
    Check dated 2026-06-10T18:09:56.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a minor update to the page's revision history without changing its content.
    Difference
    0.0%
    Check dated 2026-06-03T09:54:53.000Z thumbnail image
  9. Check
    76 days ago
    Change Detected
    Summary
    The study locations list now includes Taebuk, Chungcheongbuk-do, South Korea (28644) and previously listed Jungbuk (28644) was removed; the page revision was updated from v3.5.3 to v3.5.4.
    Difference
    0.0%
    Check dated 2026-05-19T23:08:52.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.